GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.61 $5.48 Friday, 19th Apr 2024 QURE stock ended at $4.67. This is 0.85% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 3.04% from a day low at $4.61 to a day high of $4.75.
90 days $4.61 $6.85
52 weeks $4.61 $22.48

Historical uniQure N.V. prices

Date Open High Low Close Volume
2024-02-07 $5.96 $5.96 $5.61 $5.61 548 935
2024-02-06 $5.50 $5.98 $5.37 $5.96 865 533
2024-02-05 $5.29 $5.44 $5.19 $5.42 685 668
2024-02-02 $5.50 $5.50 $5.30 $5.39 738 793
2024-02-01 $5.61 $5.65 $5.43 $5.56 1 084 889
2024-01-31 $5.73 $5.87 $5.55 $5.56 636 356
2024-01-30 $5.94 $5.95 $5.68 $5.76 777 829
2024-01-29 $5.83 $5.99 $5.63 $5.99 889 389
2024-01-26 $5.82 $5.95 $5.77 $5.83 545 462
2024-01-25 $5.72 $5.83 $5.52 $5.76 1 193 860
2024-01-24 $5.94 $5.96 $5.63 $5.65 925 972
2024-01-23 $5.91 $6.03 $5.67 $5.86 1 235 908
2024-01-22 $5.59 $5.71 $5.49 $5.70 1 205 492
2024-01-19 $5.58 $5.65 $5.47 $5.55 1 055 966
2024-01-18 $5.80 $5.87 $5.49 $5.52 1 002 576
2024-01-17 $5.75 $5.82 $5.59 $5.69 884 889
2024-01-16 $6.14 $6.16 $5.85 $5.88 1 540 029
2024-01-12 $6.42 $6.60 $6.16 $6.18 1 055 832
2024-01-11 $6.50 $6.50 $6.22 $6.32 1 269 167
2024-01-10 $6.62 $6.66 $6.24 $6.50 1 402 037
2024-01-09 $6.71 $6.84 $6.60 $6.62 662 563
2024-01-08 $6.56 $6.86 $6.34 $6.80 1 093 728
2024-01-05 $6.69 $6.69 $6.40 $6.56 625 069
2024-01-04 $6.69 $6.91 $6.56 $6.78 529 893
2024-01-03 $6.85 $6.93 $6.67 $6.68 619 582
Click to get the best stock tips daily for free!

About uniQure N.V.

uniQure N.V. uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas... QURE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT